Regulatorische Updates

Lawmaker Lee Soo-jin introduced a bill to empower the Nursing Workforce Support Center to prevent and aid recovery from workplace bullying, after a nurse's death linked to such abuse.

Huons En, a Huons Group affiliate, secured individual functional ingredient approval (No. 2026-21) from South Korea's MFDS for its Hagocho extract powder, supporting prostate health.

Qurocell announced its CAR‑T drug Rimcato has passed the HIRA Severe Disease Review Committee, clearing the first hurdle for national health‑insurance reimbursement.

South Korea's MFDS announced expanded rehabilitation support for drug addicts, linking correctional facilities with community centers and extending the 24‑hour 1342 counseling hotline to 54 prisons.

The 'Make America Healthy Again' initiative led by HHS Secretary Robert F. Kennedy Jr is prompting U.S. neighborhood pharmacies to move beyond dispensing toward preventive medicine, with PBM reforms offering a potential lifeline.

Party disagreement stalls National Assembly composition, raising questions about the resumption of health‑related committees and pending legislation.

The Korean Pharmaceutical Association held its 294th day relay protest on the 8th, urging the government to clarify herbal pharmacist licensing and improve related regulations.

Daewoong Pharma received MFDS approval for two Phase 1 studies of its olmesartan‑amlodipine‑indapamide combo (DWJ1622), assessing PK and safety in fasting (44) and fed (36) healthy adults.

The government reiterated that the 1 trillion won additional funding for health‑insurance fee‑structure reform will not draw on savings from generic drug price cuts, but from reserves, premiums and treasury support.

The Korean Pharmaceutical Association warned pharmacists that, following MFDS approval changes, the pediatric use of DiOctahexdylsMechtaite formulations is prohibited and health‑insurance coverage will cease for prescriptions from July 6 2026.

The Seoul Administrative Court ruled that a 1‑year suspension of a pharmacy operating under the drug‑separation exception in a medically underserved area is justified after it refused a Ministry of Health and Welfare on‑site inspection.

The Ministry of Health and Welfare will accept applications from August 9 to August 5 for medical institutions to join a pilot project delivering comprehensive preventive and care services at neighborhood clinics.